Until now, 37 cases harboring PROKR2 mutations presented pituitary diseases: the majority were CPHD and IGHD, followed by septo-optic dysplasia and pituitary stalk interruption syndrome (Figure 1B). This evidence concerns the gene PROKR2 and pituitary gland disorder.